Article
Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Antiviral research - 1 Jun 2016
Chung Chueh-Yao, Liu Ching-Hsuan, Burnouf Thierry, Wang Guey-Horng, Chang Shun-Pang, Jassey Alagie, Tai Chen-Jei, Tai Cheng-Jeng, Huang Ching-Jang, Richardson Christopher D, Yen Ming-Hong, Lin Chun-Ching, Lin Liang-Tzung
Abstract excerpt
Without a vaccine, hepatitis C virus (HCV) remains a global medical and socio-economic burden, predisposing about 170 million carriers worldwide to end-stage liver diseases including cirrhosis and hepatocellular carcinoma. Although the recently developed direct-acting antivirals (DAAs) have revolutionized hepatitis C treatment, most of them are unsuitable for monotherapy due to risks of resistance, thus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
